• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.39% Nasdaq Down 1.45%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    100.11 Up 0.60(0.60%) 3:20PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:99.51
    Open:99.00
    Bid:100.11 x 300
    Ask:100.17 x 100
    1y Target Est:107.06
    Beta:1.16
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:98.01 - 100.43
    52wk Range:55.04 - 100.50
    Volume:764,180
    Avg Vol (3m):1,249,430
    Market Cap:14.76B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BMRNUp 0.60%14.76B
    FOLDDown 0.97%648.85M
    SHPGUp 0.20%43.29B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):22.00
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.04
    Quarterly EPS Est (Dec-14) :-0.59
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-3.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback